Evidence map›Paper›PMID 34168114›Full record

ArticleSignal transduction and targeted therapy2021

GPR160 is a potential biomarker associated with prostate cancer.

Wanjing Guo, Junyu Zhang, Yan Zhou, Caihong Zhou, Yunjie Yang, Zhaotong Cong, Jibin Dong, Dehua Yang, Bo Dai, Ming-Wei Wang

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Signal transduction and targeted therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Wanjing Guo *The National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China.
Junyu Zhang *Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yan ZhouThe National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China.
Caihong ZhouThe National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China.
Yunjie YangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhaotong CongSchool of Pharmacy, Fudan University, Shanghai, China.
Jibin DongSchool of Pharmacy, Fudan University, Shanghai, China.
Dehua YangThe National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China. dhyang@simm.ac.cn.
Bo DaiDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. bodai1978@126.com.
Ming-Wei WangThe National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China. mwwang@simm.ac.cn.ORCID 0000-0001-6550-9017
Fudan University · CNFudan University Shanghai Cancer Center · CNShanghai Institute of Materia Medica · CNNational Center for Drug Screening · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiomarkers, TumorCell Line, TumorHumansMaleMiceMice, NudeNeoplasm ProteinsProstatic NeoplasmsReceptors, G-Protein-CoupledBiomarkers, TumorGPR160 protein, humanNeoplasm ProteinsReceptors, G-Protein-Coupled

Identifiers

PMID34168114
PMCPMC8225807
OpenAlexW3173435778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.